Replies to post #93680 on $heff's $tation of $tocks & $olid DD

[DewDiligence]

Sheff—Here’s an updated ‘cheat sheet’ for ABBV/ENTA’s global phase-3 program for ABT-493/ABT-530: #msg-122031014.

With ten phase-3 trials including 2,500 patients and trial sites in about 30 countries, no one can say that ABBV is not “all in” on this program! Regards, Dew

Disclosure: I am long ENTA.